This signature facility will be the focal point of the development, providing up to 6,000sqm of innovation, co-creation and incubation space within our Phase 1 building.
The Precision Health Technologies Accelerator (PHTA) will be dedicated to the rapid development and translation of innovative therapies and technologies from concept to clinical evaluation. By creating new opportunities for businesses and entrepreneurs to innovate and grow, and for clinical-academics in the region to commercialise their ideas, it will accelerate our ambition to be a research and innovation leader in health and life sciences.
The PHTA builds on BHP’s nationally-recognised strengths and will support businesses through access to expertise in:
- the development and delivery of complex clinical trials
- complex diagnostics, multi-omics analysis and heath data
- device evaluation and testing
- regulatory science and innovation
The PHTA will provide the early incubation, grow-on space and innovation services for businesses working across biopharma, advanced therapies, diagnostics, digital health and healthcare technologies to accelerate the development and delivery of new drugs, diagnostics and devices into clinic. Its incubation services for early-stage businesses are set to include wet labs, dry labs and office spaces, and prototype development facilities.
Data: connecting the patient context
Delivering safe and secure access to integrated, curated, real-world healthcare data from across and beyond our region, enabling a detailed understanding at patient and population level.
Diagnostics: understanding the disease
Bringing together leading regional genomics and immunodiagnostic research and services to deliver precision medicine, validation of new therapies and development of sophisticated diagnostics.
Healthcare technologies: developing the solutions
Rapidly develop, test and adopt new technologies, providing facilities and expertise to undertake early stage research, product development and validation, through to prototype manufacture and pre-clinical and clinical evaluation.
Clinical trials & implementation: deploying real-world innovation
Recognised leadership in novel clinical trials design and delivery together with leading expertise in patient reported outcomes measures to help partners deliver accelerated trials and demonstrate value.
And, by putting the patient at the heart of all our activity, we will focus on the innovations that address prevalent health burdens in our region’s population – with the ultimate aim of scaling these solutions to the rest of the UK and potentially wider world.
For more details on the Precision Health Technologies Accelerator contact us using the details below.